These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24431918)

  • 1. The successful implantation of continuous-flow left ventricular assist device as a destination therapy in Korea: echocardiographic assessment.
    Lee GY; Park SJ; Kim S; Choi N; Jeong DS; Jeon ES; Lee YT
    J Korean Med Sci; 2014 Jan; 29(1):137-40. PubMed ID: 24431918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of continuous-flow left ventricular assist devices.
    Neyt M; Van den Bruel A; Smit Y; De Jonge N; Erasmus M; Van Dijk D; Vlayen J
    Int J Technol Assess Health Care; 2013 Jul; 29(3):254-60. PubMed ID: 23763844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with the HeartMate II Left Ventricular Assist Device in Patients Older than 60 Years.
    Demirozu ZT; Critsinelis A; Cohn WE; Radovancevic R; Ho J; Hernandez R; Morgan JA; Frazier OH
    Heart Surg Forum; 2019 Mar; 22(2):E124-E130. PubMed ID: 31013222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of a left ventricular assist device as destination therapy versus guideline-directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) trial.
    Karason K; Lund LH; Dalén M; Björklund E; Grinnemo K; Braun O; Nilsson J; van der Wal H; Holm J; Hübbert L; Lindmark K; Szabo B; Holmberg E; Dellgren G;
    Eur J Heart Fail; 2020 Apr; 22(4):739-750. PubMed ID: 32100946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalisation of haemodynamics in patients with end-stage heart failure with continuous-flow left ventricular assist device therapy.
    Gupta S; Woldendorp K; Muthiah K; Robson D; Prichard R; Macdonald PS; Keogh AM; Kotlyar E; Jabbour A; Dhital K; Granger E; Spratt P; Jansz P; Hayward CS
    Heart Lung Circ; 2014 Oct; 23(10):963-9. PubMed ID: 24973864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transthoracic echocardiographic assessment of continuous-flow left ventricular assist devices.
    Rasalingam R; Johnson SN; Bilhorn KR; Huang PH; Makan M; Moazami N; Pérez JE
    J Am Soc Echocardiogr; 2011 Feb; 24(2):135-48. PubMed ID: 21236640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First clinical implant of the VentrAssist left ventricular assist system as destination therapy for end-stage heart failure.
    Esmore DS; Kaye D; Salamonsen R; Buckland M; Rowland M; Negri J; Rowley Y; Woodard J; Begg JR; Ayre P; Rosenfeldt FL
    J Heart Lung Transplant; 2005 Aug; 24(8):1150-4. PubMed ID: 16102463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regenerating a ventricular cavity during left ventricular assist device implantation.
    Altas O; Ozer T; Ozgur MM; Sarikaya S; Kirali K
    J Artif Organs; 2019 Jun; 22(2):169-172. PubMed ID: 30684042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome.
    Topilsky Y; Hasin T; Oh JK; Borgeson DD; Boilson BA; Schirger JA; Clavell AL; Frantz RP; Tsutsui R; Liu M; Maltais S; Kushwaha SS; Pereira NL; Park SJ
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):648-61. PubMed ID: 21940507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Destination therapy: does progress depend on left ventricular assist device development?
    von Bayern MP; Cadeiras M; Deng MC
    Heart Fail Clin; 2007 Jul; 3(3):349-67. PubMed ID: 17723941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients.
    Rogers JG; Aaronson KD; Boyle AJ; Russell SD; Milano CA; Pagani FD; Edwards BS; Park S; John R; Conte JV; Farrar DJ; Slaughter MS;
    J Am Coll Cardiol; 2010 Apr; 55(17):1826-34. PubMed ID: 20413033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placement of a continuous-flow ventricular assist device in the failing ventricle of an adult patient with complex cyanotic congenital heart disease.
    Morris CD; Gregoric ID; Cooley DA; Cohn WE; Loyalka P; Frazier OH
    Heart Surg Forum; 2008; 11(3):E143-4. PubMed ID: 18583283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiographic findings in stable outpatients with properly functioning HeartMate II left ventricular assist devices.
    Topilsky Y; Oh JK; Atchison FW; Shah DK; Bichara VM; Schirger JA; Kushwaha SS; Pereira NL; Park SJ
    J Am Soc Echocardiogr; 2011 Feb; 24(2):157-69. PubMed ID: 21281909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymptomatic Sustained Polymorphic Ventricular Tachycardia in a Patient with a Left Ventricular Assist Device: Case Report and what the Emergency Physician Should Know.
    Fitzgibbon J; Kman NE; Gorgas D
    J Emerg Med; 2016 Mar; 50(3):e135-41. PubMed ID: 26899195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further Peripheral Vascular Dysfunction in Heart Failure Patients With a Continuous-Flow Left Ventricular Assist Device: The Role of Pulsatility.
    Witman MA; Garten RS; Gifford JR; Groot HJ; Trinity JD; Stehlik J; Nativi JN; Selzman CH; Drakos SG; Richardson RS
    JACC Heart Fail; 2015 Sep; 3(9):703-11. PubMed ID: 26277768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(3):1-60. PubMed ID: 27026798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.